Acetyl-DL-leucine in two individuals with REM sleep behavior disorder improves symptoms, reverses loss of striatal dopamine-transporter binding and stabilizes pathological metabolic brain pattern—case reports:
nature.com/articles/s41467-....
In 2020, we treated a PD patient, who also suffered from Restless Legs Syndrome (RLS) and the phenotype RBD, with the modified amino acid acetyl-D-leucine (ADLL; 5 g/day orally). Within 2 weeks after initiating ADLL treatment, the patient’s RLS symptoms had substantially abated